Stock BGD BIOGENED S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Biogened S.A.

Equities

BGD

PLBIOGN00018

Pharmaceuticals

End-of-day quote Warsaw S.E.
Other stock markets
 06:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
22.4 PLN -2.61% Intraday chart for Biogened S.A. +1.82% +24.44%
Feb. 14 Biogened S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
2023 Biogened S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 31.05 20.39 17.19 20.88 21.12 31.2
Enterprise Value (EV) 1 50.74 41.81 38.06 35.42 34.86 50.72
P/E ratio 31 x 17.9 x 13.5 x 16.8 x 10.8 x 9.23 x
Yield - - - 2.35% - 3.15%
Capitalization / Revenue 0.92 x 0.51 x 0.37 x 0.43 x 0.32 x 0.39 x
EV / Revenue 1.51 x 1.04 x 0.82 x 0.73 x 0.53 x 0.64 x
EV / EBITDA 7.47 x 5.83 x 5.01 x 5.24 x 4.72 x 4.5 x
EV / FCF 42.9 x -54.4 x 214 x 2.38 x 4.46 x -16.6 x
FCF Yield 2.33% -1.84% 0.47% 41.9% 22.4% -6.04%
Price to Book 0.6 x 0.39 x 0.32 x 0.38 x 0.71 x 0.96 x
Nbr of stocks (in thousands) 2,456 2,456 2,456 2,456 2,456 2,456
Reference price 2 12.64 8.300 7.000 8.500 8.600 12.70
Announcement Date 5/17/18 5/14/19 5/14/20 5/13/21 5/30/22 5/30/23
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 33.57 40.24 46.63 48.33 65.32 79.62
EBITDA 1 6.797 7.171 7.604 6.761 7.388 11.28
EBIT 1 2.926 3.393 3.348 2.359 4.589 8.376
Operating Margin 8.72% 8.43% 7.18% 4.88% 7.03% 10.52%
Earnings before Tax (EBT) 1 1.729 1.986 1.927 2.176 4.329 6.39
Net income 1 1.001 1.137 1.272 1.242 1.961 3.381
Net margin 2.98% 2.83% 2.73% 2.57% 3% 4.25%
EPS 2 0.4076 0.4629 0.5177 0.5054 0.7982 1.377
Free Cash Flow 1 1.184 -0.7691 0.1781 14.86 7.82 -3.065
FCF margin 3.53% -1.91% 0.38% 30.74% 11.97% -3.85%
FCF Conversion (EBITDA) 17.42% - 2.34% 219.74% 105.84% -
FCF Conversion (Net income) 118.23% - 14.01% 1,196.6% 398.84% -
Dividend per Share - - - 0.2000 - 0.4000
Announcement Date 5/17/18 5/14/19 5/14/20 5/13/21 5/30/22 5/30/23
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 19.7 21.4 20.9 14.5 13.7 19.5
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.898 x 2.987 x 2.744 x 2.151 x 1.859 x 1.73 x
Free Cash Flow 1 1.18 -0.77 0.18 14.9 7.82 -3.06
ROE (net income / shareholders' equity) 1.96% 2.18% 2.38% 2.28% 4.63% 10.8%
ROA (Net income/ Total Assets) 2.34% 2.62% 2.5% 1.75% 3.97% 7.91%
Assets 1 42.73 43.41 50.83 70.77 49.36 42.73
Book Value Per Share 2 21.00 21.50 22.00 22.30 12.20 13.30
Cash Flow per Share 2 0.4200 0.4300 0.4900 1.040 2.020 1.410
Capex 1 4.18 4.47 3.67 1.83 1.57 9.36
Capex / Sales 12.44% 11.1% 7.87% 3.79% 2.4% 11.76%
Announcement Date 5/17/18 5/14/19 5/14/20 5/13/21 5/30/22 5/30/23
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
BIOGENED S.A. Stock Biogened S.A.
+24.44% 14.04M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.63% 44.11B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+23.03% 22.71B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.22% 15.15B
CIPLA LIMITED Stock Cipla Limited
+12.66% 13.56B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+60.18% 12.7B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.02% 6.84B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.92% 5.63B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BGD Stock
  4. Financials Biogened S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW